Ascendis Pharma A/S is a biopharmaceutical company that focuses on developing innovative drug therapies for unmet medical needs. The company employs its proprietary TransCon technology platform to cre... Ascendis Pharma A/S is a biopharmaceutical company that focuses on developing innovative drug therapies for unmet medical needs. The company employs its proprietary TransCon technology platform to create therapeutic products that improve efficacy and therapeutic outcomes. Ascendis Pharma primarily targets endocrinology, aiming to treat conditions such as growth hormone deficiencies and hypoparathyroidism. The company's commitment to integrating advanced biotechnology through TransCon allows for sustained release and limited side effects, offering efficient and effective treatment options. Headquartered in Denmark, Ascendis Pharma plays a significant role in the biotech sector, driving innovation with a strong emphasis on developmental pipeline and collaborations designed to address complex diseases. With its growing presence and dedicated R&D initiatives, Ascendis continues to make critical contributions to the healthcare industry by delivering promising new therapies for rare conditions.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

Ascendis Pharma is not subject to EU Taxonomy reporting

Based on current regulatory requirements, Ascendis Pharma is not required to report EU Taxonomy data under the CSRD framework. As a result, we have not conducted a detailed EU Taxonomy data review for this company.

If you believe this assessment should be revisited, you may submit a data coverage request and our team will review the company's regulatory applicability.

Would you like us to review Ascendis Pharma's data?

Start your 30-day free trial to request a data review for Ascendis Pharma.

Start Free Trial

Legal Center Contact Us